Core funding for the IRCAN is provided by the University Côte d'Azur, the CNRS and the INSERM
Research projects from the team are supported by:
Current funding
"The FGF/FGFR signalling pathway : a novel therapeutic target in liposarcoma"
Institut National du Cancer (2017-2020)
"The FGF/FGFR pathway : a novel therapeutic target in dedifferentiated liposarcomas"
Association GEMLUC (2016)
"The SDC1/FGF/FGFR pathway : a novel therapeutic target in liposarcoma"
The Alan B. Slifka Foundation (2016)
Selected past funding
"The FGF/FGFR pathway : a novel therapeutic target in dedifferentiated liposarcomas"
Association Française de Patients InfoSarcomes (2015)